Skelaxin News

• U.S. drug maker makes bid for a rival (International Herald Tribune)
  King Pharmaceuticals submitted a $1.4 billion cash bid for Alpharma and threatened to turn hostile if the company's board refuses to accept the bid.



• King says Alpharma rebuffed a $1.4B buyout bid (Lexington Herald-Leader)
  King Pharmaceuticals Inc. said Friday that rival Alpharma Inc. has rejected a $1.4 billion buyout offer but indicated it is prepared to take the bid directly to shareholders in a move to expand its product offerings. The Bristol, Tenn.-based drugmaker disclosed the $33 a share offer publicly for the first time on Friday. It said the offer was rejected by Alpharma, following a letter to that ...



• King Pharmaceuticals says Alpharma rebuffed a US$1.4B buyout bid (The Canadian Press via Yahoo! Canada News)
  NEW YORK - King Pharmaceuticals Inc. said Friday that rival Alpharma Inc. has rejected a US$1.4 billion buyout offer but indicated it is prepared to take the bid directly to shareholders in a move to expand its product offerings.



• Police: Man tries to swallow evidence (New Hampshire Union Leader)
  A 40-year-old city resident is accused of having a prescription narcotic and other pills in his car and scuffling with police when they tried to arrest him on the West Side on Thursday night.



• Alpharma Rejects King's Advances (Forbes)
  The pain drug manufacturer continues to turn down the company's 'undervaluing' $1.4 billion offer.



• N.J. drugmaker rejects buyout offer (Asbury Park Press)
  King Pharmaceuticals Inc. said today that rival Alpharma Inc. has rejected a $1.4 billion buyout offer but indicated it is prepared to take the bid directly to shareholders in a move to expand its product offerings.



• King says Alpharma rebuffed a $1.4B buyout bid (AP via Yahoo! News)
  King Pharmaceuticals Inc. said Friday that rival Alpharma Inc. has rejected a $1.4 billion buyout offer but indicated it is prepared to take the bid directly to shareholders in a move to expand its product offerings.



• Alpharma Not Interested In Being King's Queen (Forbes)
  The pain-drug manufacturer reveals a bid for it competitor, whose board has already said "no thanks."



• Alpharma shares surge on King buyout offer (AP via Yahoo! Finance)
  Shares of Alpharma Inc. surged Friday, as investors wagered the stock is worth more than the $33 per share buyout price offered by King Pharmaceuticals Inc. in its $1.4 billion cash bid.